SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-20-021866
Filing Date
2020-11-17
Accepted
2020-11-17 17:28:12
Documents
12
Period of Report
2020-11-10
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 34865
  Complete submission text file 0001493152-20-021866.txt   209531

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE abeo-20201110.xsd EX-101.SCH 3216
3 XBRL LABEL FILE abeo-20201110_lab.xml EX-101.LAB 34591
4 XBRL PRESENTATION FILE abeo-20201110_pre.xml EX-101.PRE 22730
5 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3615
Mailing Address 1330 AVENUE OF THE AMERICAS, 33RD FLOOR NEW YORK NY 10019
Business Address 1330 AVENUE OF THE AMERICAS, 33RD FLOOR NEW YORK NY 10019 646-813-4701
ABEONA THERAPEUTICS INC. (Filer) CIK: 0000318306 (see all company filings)

IRS No.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-15771 | Film No.: 201322144
SIC: 2834 Pharmaceutical Preparations